Proangiogenic factors in the development of HCC in alcoholic cirrhosis
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 39, S104-S108
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Delayed Diagnosis of HCC with Chronic Alcoholic Liver DiseaseLiver Cancer, 2012
- Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver DiseasesHepatology, 2011
- Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular CarcinomaJournal of Clinical Oncology, 2011
- Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung CancerClinical Cancer Research, 2011
- Hypoxia‐inducible factor‐dependent production of profibrotic mediators by hypoxic hepatocytesLiver International, 2009
- Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosisBritish Journal of Pharmacology, 2009
- Reduced liver fibrosis in hypoxia-inducible factor-1α-deficient miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?European Journal of Gastroenterology & Hepatology, 2005
- Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma developmentJournal of Hepatology, 2004
- Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in miceHepatology, 2004